<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>DNA Repair &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/dna-repair/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 09 Jan 2026 16:14:52 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>DNA Repair &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>MTHFD2: Key to DNA Repair and LUAD Resistance</title>
		<link>https://bioengineer.org/mthfd2-key-to-dna-repair-and-luad-resistance/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 09 Jan 2026 16:14:39 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[DNA Repair]]></category>
		<category><![CDATA[lung adenocarcinoma]]></category>
		<category><![CDATA[metabolic pathways]]></category>
		<category><![CDATA[MTHFD2]]></category>
		<category><![CDATA[radiotherapy resistance]]></category>
		<guid isPermaLink="false">https://bioengineer.org/mthfd2-key-to-dna-repair-and-luad-resistance/</guid>

					<description><![CDATA[In a groundbreaking study soon to be published in the Journal of Translational Medicine, researchers have unveiled compelling evidence that MTHFD2, a crucial metabolic enzyme, plays a pivotal role in DNA repair mechanisms, thereby contributing to resistance against radiotherapy in lung adenocarcinoma (LUAD). This discovery could radically reshape our understanding of cancer treatment paradigms, especially [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">315343</post-id>	</item>
		<item>
		<title>C1orf50: Key Player in Ovarian Cancer Dynamics</title>
		<link>https://bioengineer.org/c1orf50-key-player-in-ovarian-cancer-dynamics/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 13 Dec 2025 04:50:35 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[C1orf50]]></category>
		<category><![CDATA[DNA Repair]]></category>
		<category><![CDATA[Immune Modulation]]></category>
		<category><![CDATA[Ovarian cancer]]></category>
		<category><![CDATA[Pan-Cancer Profiling]]></category>
		<guid isPermaLink="false">https://bioengineer.org/c1orf50-key-player-in-ovarian-cancer-dynamics/</guid>

					<description><![CDATA[Recent research has shed light on the intricate relationship between genetic factors and the progression of ovarian cancer, a malignancy known for its aggressive nature and poor prognosis. In a groundbreaking study led by Rogachevskaya et al., evidence from pan-cancer profiling has linked the gene C1orf50 to essential processes in DNA repair and immune modulation [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">307118</post-id>	</item>
	</channel>
</rss>
